NASDAQ:ANAC

Arctos NorthStar Acquisition (ANAC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$10.19
$10.19
50-Day Range
$9.68
$9.79
52-Week Range
$9.44
$10.20
Volume
705 shs
Average Volume
53,611 shs
Market Capitalization
$402.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ANAC stock logo

About Arctos NorthStar Acquisition Stock (NASDAQ:ANAC)

Arctos NorthStar Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It focuses on sports, media, and entertainment sectors. The company was founded in 2020 and is based in Dallas, Texas.

ANAC Stock News Headlines

Northstar Clean Technologies Inc ROOF
Metal Sky Star Acquisition Corp
Northstar California Resort
Arctos Northstar Acquisition Corp
ANAC_u Technical Analysis
Arctos Northstar Acquisition Corp (ANAC)
Arctos Northstar Acquisition Corp Unit (ANAC_u)
Arctos NorthStar Acquisition Corp. Cl A
Arctos NorthStar Acquisition Corp. Wt
See More Headlines
Receive ANAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arctos NorthStar Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/10/2016
Today
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ANAC
CUSIP
03242010
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$7.16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.18 per share
Book Value
($0.63) per share

Miscellaneous

Free Float
N/A
Market Cap
$402.81 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

ANAC Stock Analysis - Frequently Asked Questions

How were Arctos NorthStar Acquisition's earnings last quarter?

Arctos NorthStar Acquisition Corp. (NASDAQ:ANAC) released its quarterly earnings results on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.35) by $0.01. The biopharmaceutical company had revenue of $17.54 million for the quarter, compared to analysts' expectations of $19.53 million. The firm's revenue for the quarter was up 14.9% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.30) earnings per share.

What other stocks do shareholders of Arctos NorthStar Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Arctos NorthStar Acquisition investors own include Micron Technology (MU), Portola Pharmaceuticals (PTLA), bluebird bio (BLUE), Netflix (NFLX), BioMarin Pharmaceutical (BMRN), Intercept Pharmaceuticals (ICPT), NXP Semiconductors (NXPI) and ACADIA Pharmaceuticals (ACAD).

This page (NASDAQ:ANAC) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners